NCT00980694View on ClinicalTrials.gov

Bioavailability of Ubiquinol in Huntington Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Huntington Disease
Interventions
DIETARY_SUPPLEMENT

ubiquinol

up to 600 mg per day, oral capsules for 8 weeks

Trial Locations (1)

14618

University of Rochester, Rochester

Sponsors

Collaborators (1)

Kaneka Corporation
All Listed Sponsors
collaborator

Kaneka Corporation

INDUSTRY

lead

University of Rochester

OTHER

NCT00980694 - Bioavailability of Ubiquinol in Huntington Disease | Biotech Hunter | Biotech Hunter